116 related articles for article (PubMed ID: 10555752)
1. The role of endogenous interleukin-2 in proliferation of human carcinoma cell lines.
Reichert TE; Kashii Y; Stanson J; Zeevi A; Whiteside TL
Br J Cancer; 1999 Nov; 81(5):822-31. PubMed ID: 10555752
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-2 expression in human carcinoma cell lines and its role in cell cycle progression.
Reichert TE; Nagashima S; Kashii Y; Stanson J; Gao G; Dou QP; Whiteside TL
Oncogene; 2000 Jan; 19(4):514-25. PubMed ID: 10698521
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of the IL-2 receptor beta chain gene expressed in human tumor cells.
Suminami Y; Kashii Y; Law JC; Lin WC; Stanson J; Reichert TE; Rabinowich H; Whiteside TL
Oncogene; 1998 Mar; 16(10):1309-17. PubMed ID: 9546432
[TBL] [Abstract][Full Text] [Related]
4. Constitutive production of IL-2 by human carcinoma cells, expression of IL-2 receptor, and tumor cell growth.
Lin WC; Yasumura S; Suminami Y; Sung MW; Nagashima S; Stanson J; Whiteside TL
J Immunol; 1995 Nov; 155(10):4805-16. PubMed ID: 7594483
[TBL] [Abstract][Full Text] [Related]
5. Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situ.
Weidmann E; Sacchi M; Plaisance S; Heo DS; Yasumura S; Lin WC; Johnson JT; Herberman RB; Azzarone B; Whiteside TL
Cancer Res; 1992 Nov; 52(21):5963-70. PubMed ID: 1394222
[TBL] [Abstract][Full Text] [Related]
6. Endogenous IL-2 in cancer cells: a marker of cellular proliferation.
Reichert TE; Watkins S; Stanson J; Johnson JT; Whiteside TL
J Histochem Cytochem; 1998 May; 46(5):603-11. PubMed ID: 9562569
[TBL] [Abstract][Full Text] [Related]
7. Growth stimulation of human head and neck squamous cell carcinoma cell lines by interleukin 4.
Myers JN; Yasumura S; Suminami Y; Hirabayashi H; Lin Wc; Johnson JT; Lotze MT; Whiteside TL
Clin Cancer Res; 1996 Jan; 2(1):127-35. PubMed ID: 9816099
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.
Nagashima S; Reichert TE; Kashii Y; Suminami Y; Chikamatsu K; Whiteside TL
Cancer Gene Ther; 1997; 4(6):366-76. PubMed ID: 9408607
[TBL] [Abstract][Full Text] [Related]
9. Downmodulation of TGF-alpha protein expression with antisense oligonucleotides inhibits proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells.
Grandis JR; Chakraborty A; Zeng Q; Melhem MF; Tweardy DJ
J Cell Biochem; 1998 Apr; 69(1):55-62. PubMed ID: 9513046
[TBL] [Abstract][Full Text] [Related]
10. EGFR antisense treatment of human HNSCC cell lines down-regulates VEGF expression and endothelial cell migration.
Riedel F; Götte K; Li M; Hörmann K; Grandis JR
Int J Oncol; 2002 Jul; 21(1):11-6. PubMed ID: 12063543
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells.
Rubin Grandis J; Chakraborty A; Melhem MF; Zeng Q; Tweardy DJ
Oncogene; 1997 Jul; 15(4):409-16. PubMed ID: 9242377
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-2 enhances the growth of human melanoma cells derived form primary but not from metastatic tumours.
García-Vázquez MD; Boyano MD; Cañavate ML; Gardeazabal J; de Galdeano AG; López-Michelena T; Ratón JA; Izu R; Díaz-Ramón JL; Díaz-Pérez JL
Eur Cytokine Netw; 2000 Dec; 11(4):654-61. PubMed ID: 11125310
[TBL] [Abstract][Full Text] [Related]
13. Surface membrane-expressed CD40 is present on tumor cells from squamous cell cancer of the head and neck in vitro and in vivo and regulates cell growth in tumor cell lines.
Posner MR; Cavacini LA; Upton MP; Tillman KC; Gornstein ER; Norris CM
Clin Cancer Res; 1999 Aug; 5(8):2261-70. PubMed ID: 10473114
[TBL] [Abstract][Full Text] [Related]
14. Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo.
Riedel F; Götte K; Li M; Hörmann K; Grandis JR
Int J Oncol; 2003 Sep; 23(3):577-83. PubMed ID: 12888890
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the participation of interleukin-2 (IL-2) and IL-4 in the regulation of autonomous growth and tumorigenesis of transformed cells of lymphoid origin.
Hassuneh MR; Nagarkatti PS; Nagarkatti M
Blood; 1997 Jan; 89(2):610-20. PubMed ID: 9002965
[TBL] [Abstract][Full Text] [Related]
16. Transfer of interleukin 2 receptor genes into squamous cell carcinoma. Modification of tumor cell growth.
Lin WC; Yasumura S; Whiteside TL
Arch Otolaryngol Head Neck Surg; 1993 Nov; 119(11):1229-35. PubMed ID: 8217083
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 13 is secreted by human head and neck tumours and does not modulate their growth in vitro.
Mehrotra R
Indian J Exp Biol; 1998 Aug; 36(8):805-7. PubMed ID: 9838882
[TBL] [Abstract][Full Text] [Related]
18. Concentrations of cyclosporin A and FK506 that inhibit IL-2 induction in human T cells do not affect TGF-beta1 biosynthesis, whereas higher doses of cyclosporin A trigger apoptosis and release of preformed TGF-beta1.
Minguillón J; Morancho B; Kim SJ; López-Botet M; Aramburu J
J Leukoc Biol; 2005 May; 77(5):748-58. PubMed ID: 15716327
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 2 receptor expression and interleukin 2 localisation in human solid tumor cells in situ and in vitro: evidence for a direct role in the regulation of tumour cell proliferation.
McMillan DN; Kernohan NM; Flett ME; Heys SD; Deehan DJ; Sewell HF; Walker F; Eremin O
Int J Cancer; 1995 Mar; 60(6):766-72. PubMed ID: 7896442
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 2 exerts autocrine stimulation on murine T-cell leukaemia growth.
Waldner CI; Mongini C; Alvarez E; Sánchez Lockhart M; Gravisaco MJ; Hajos SE
Br J Cancer; 1997; 75(7):946-50. PubMed ID: 9083328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
